A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06030076 · RECRUITING
Trial details
- NCT number
- NCT06030076
- Sponsor
- Almirall, S.A.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-06
- Primary completion
- 2025-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.